[{"address1": "11750 Sorrento Valley Road", "address2": "Suite 200", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "979 446 0027", "website": "https://ibioinc.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases. The company's technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies against the desired regions of the target protein. Its product pipelines for cardiometabolic disease area include IBIO-101, an anti-CD25 Mab that binds and depletes immunosuppressive regulatory treg cells to inhibit the growth of solid tumors; CCR8, an antibody that enhance the body's immune response against cancer cells; and trophoblast cell surface antigen 2, a monoclonal antibodies, as well as MUC16 and Target 5 antibodies. In addition, the company is developing EGFRvIII, an antibody therapeutics that targets EGFRvIII protein with the aim to address these cancer types without affecting healthy cells. It has a collaboration agreement with AstralBio to discover and develop novel antibodies for obesity and other cardiometabolic diseases. iBio, Inc. was incorporated in 2008 and is headquartered in San Diego, California.", "fullTimeEmployees": 16, "companyOfficers": [{"maxAge": 1, "name": "Dr. Martin B. Brenner D.V.M., Ph.D.", "age": 54, "title": "CEO, Chief Scientific Officer & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 753000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Felipe  Duran", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 513224, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Marc  Banjak J.D.", "title": "Chief Legal Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kristi  Sarno", "title": "Senior VP of Business Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 4, "overallRisk": 7, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.728, "open": 0.72, "dayLow": 0.72, "dayHigh": 0.8184, "regularMarketPreviousClose": 0.728, "regularMarketOpen": 0.72, "regularMarketDayLow": 0.72, "regularMarketDayHigh": 0.8184, "payoutRatio": 0.0, "beta": 1.19, "forwardPE": -0.4875, "volume": 672909, "regularMarketVolume": 672909, "averageVolume": 1253095, "averageVolume10days": 1213000, "averageDailyVolume10Day": 1213000, "bid": 0.7772, "ask": 0.8282, "bidSize": 6, "askSize": 4, "marketCap": 13207180, "fiftyTwoWeekLow": 0.64, "fiftyTwoWeekHigh": 6.89, "priceToSalesTrailing12Months": 35.219147, "fiftyDayAverage": 2.597, "twoHundredDayAverage": 2.6191, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 12568165, "profitMargins": 0.0, "floatShares": 15843973, "sharesOutstanding": 16519300, "sharesShort": 1732094, "sharesShortPriorMonth": 1172123, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.1721, "heldPercentInsiders": 0.043070003, "heldPercentInstitutions": 0.15777999, "shortRatio": 0.88, "shortPercentOfFloat": 0.1723, "impliedSharesOutstanding": 16728400, "bookValue": 1.131, "priceToBook": 0.70689654, "lastFiscalYearEnd": 1719705600, "nextFiscalYearEnd": 1751241600, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -16460000, "trailingEps": -0.04, "forwardEps": -1.64, "lastSplitFactor": "1:20", "lastSplitDate": 1701216000, "enterpriseToRevenue": 33.515, "enterpriseToEbitda": -0.784, "52WeekChange": -0.6604651, "SandP52WeekChange": 0.11469197, "quoteType": "EQUITY", "currentPrice": 0.7995, "targetHighPrice": 6.0, "targetLowPrice": 3.6, "targetMeanPrice": 4.86667, "targetMedianPrice": 5.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 4959000, "totalCashPerShare": 0.3, "ebitda": -16021000, "totalDebt": 4320000, "quickRatio": 0.919, "currentRatio": 1.123, "totalRevenue": 375000, "debtToEquity": 37.958, "revenuePerShare": 0.041, "returnOnAssets": -0.30345, "returnOnEquity": -0.90829, "grossProfits": 375000, "freeCashflow": 17670376, "operatingCashflow": -15543000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -44.834667, "financialCurrency": "USD", "symbol": "IBIO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "exchange": "NCM", "messageBoardId": "finmb_33000", "exchangeTimezoneName": "America/New_York", "regularMarketPrice": 0.7995, "corporateActions": [], "regularMarketChangePercent": 9.821429, "postMarketTime": 1747439925, "regularMarketTime": 1747425602, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1219152600000, "postMarketChangePercent": -1.18824, "postMarketPrice": 0.79, "postMarketChange": -0.00949997, "regularMarketChange": 0.0715, "regularMarketDayRange": "0.72 - 0.8184", "longName": "iBio, Inc.", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1253095, "fiftyTwoWeekLowChange": 0.1595, "fiftyTwoWeekLowChangePercent": 0.24921876, "fiftyTwoWeekRange": "0.64 - 6.89", "fiftyTwoWeekHighChange": -6.0905, "fiftyTwoWeekHighChangePercent": -0.8839623, "fiftyTwoWeekChangePercent": -66.04651, "dividendDate": 1528675200, "earningsTimestamp": 1746187200, "earningsTimestampStart": 1746187200, "earningsTimestampEnd": 1746187200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.04, "epsForward": -1.64, "epsCurrentYear": -1.77, "priceEpsCurrentYear": -0.4516949, "fiftyDayAverageChange": -1.7974999, "fiftyDayAverageChangePercent": -0.69214475, "twoHundredDayAverageChange": -1.8196001, "twoHundredDayAverageChangePercent": -0.6947425, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2025-03-04", "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "shortName": "iBio, Inc.", "displayName": "iBio", "trailingPegRatio": null, "__fetch_time": "2025-05-17"}]